9th Annual Symposium

GRIDS 2023

From Asymptomatic to Severe, the Variability in Lysosomal Storage Disorders:
Integrating the Basics with Current Clinical Practices

November 19th – 20th, 2023
Salamander Middleburg · Middleburg, Virginia, USA

About the Event

9th Annual GRIDSymposium

Event Overview

Lysosomal disorders pose significant challenges for therapy due to their complex nature and phenotypic variability. Advancements in understanding lysosomal biology have shed light on their dynamic role in cellular functions and the development of pathology. With the emergence of novel technologies such as gene therapy and genome editing, diagnostic advancements, biomarkers, and companion diagnostics, the field is rapidly evolving. The Genetic, Rare and Immune Disorders Symposium (GRIDS) 2023 brings together clinicians, researchers, and advocacy groups to exchange knowledge, promote collaboration, and enhance the diagnosis and treatment of lysosomal disorders — ultimately improving the lives of patients.

Program Highlights

  • Basic Mechanisms in Lysosomal Disorders: Phenotypic Diversity and Cell Biology
  • Biomarkers and other genetic approaches in LSDs
  • The Application of Novel Technologies in LSDs: Role of AI in Lysosomal Disorders
  • Next-generation therapies in LSDs
  • Current Clinical Challenges in Lysosomal Disorders: Phenotypic diversity and clinical management
  • Newborn screening and LSDs in the neonatal period

Keynote Speaker

Konrad Sandhoff, PhD University of Bonn, Germany

Confirmed Speakers

Aimee Donald, PhDNIHR Academic Clinical Lecturer, University of Manchester, UK
Alexey V. Pshezhetsky, PhDDepartments of Pediatrics and Biochemistry, University of Montreal, Canada
Andrea Dardis, PhDUniversity Hospital "Santa Maria della Misericordia", Italy
Can Ficicioglu, MD, PhDCHOP, Pennsylvania, USA
Caroline Hastings, MDChildren's Hospital & Research Center Oakland, California, USA
David Kronn, MDMaria Fareri Children's Hospital, New York Medical College, USA
Debra S. Regier, MD, PhDChildren's National Medical Center, Washington DC, USA
Elizabeth Jalazo, MDUniversity of North Carolina, USA
Gregory A. Grabowski, MDUniversity of Cincinnati College of Medicine, Ohio, USA
Guilherme Baldo, PhDUniversidade Federal do Rio Grande do Sul, Brazil
Gustavo Maegawa, MD, PhDColumbia University Irving Medical Center, New York, USA
John Lynn Jefferies, MDUniversity of Tennessee Health Science Center, USA
Joseph Muenzer, MD, PhDUniversity of North Carolina, USA
Magy Abdel Wahab, MDCairo University Pediatric Hospital, Egypt
Mia Horowitz, PhDTel Aviv University, Israel
Orna Staretz-Chacham, MDSoroka Medical Centre, Israel
Pilar Giraldo, MDInstituto de Investigación Sanitaria Aragón, Spain
Shawn M. Ferguson, PhDYale School of Medicine, Connecticut, USA
Shoshana Revel-Vilk, MDShaare Zedek Medical Center, Jerusalem, Israel
Neil Kasaci★ Young Investigator · LDRTC, Virginia, USA

Sessions

Agenda Overview

Day 1 — November 19th, 2023
Session I: Basic Mechanisms in Lysosomal Disorders — Phenotypic Diversity and Cell Biology
Session II: Biomarkers and Other Genetic Approaches in LSDs
Session III: Current Clinical Challenges in Lysosomal Disorders — Newborn Screening and LSD in the Neonatal Period
Session IV: The Application of Novel Technologies in LSD — Role of AI in Lysosomal Disorders
Day 2 — November 20th, 2023
Session V: Next-Generation Therapies in LSDs
Session VI: Current Challenges in Lysosomal Disorders

Continuing Education

Enduring CMEs

Enduring CME with up to 2 hours of CME credit per session.

Session 1

Basic Mechanism in Lysosomal Disorders: Phenotypic Diversity and Cell Biology

Access CME →
Session 2

Biomarkers and Other Genetic Approaches in LDs

Access CME →
Session 3

Newborn Screening and LSDs in the Neonatal Period

Access CME →
Session 4

Role of AI in Lysosomal Disorders: Big Data to Artificial Intelligence and Challenges

Access CME →
Session 5

Next Generation Therapies in LDs

Access CME →
Session 6

Current Challenges in Lysosomal Disorders

Access CME →